Variant report
Variant | esv17159 |
---|---|
Chromosome Location | chr5:101093096-101108930 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:101078843..101080982-chr5:101098462..101100344,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs544761017 | chr5:101093802-101093803 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs372602199 | chr5:101093833-101093834 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs115775991 | chr5:101093855-101093856 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs4703181 | chr5:101093872-101093873 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs59449697 | chr5:101093873-101093874 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs559464394 | chr5:101093926-101093927 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs139861145 | chr5:101093942-101093943 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs112463303 | chr5:101093943-101093944 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs551896915 | chr5:101094024-101094025 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs563483582 | chr5:101094086-101094087 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs184757908 | chr5:101094092-101094093 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs74635363 | chr5:101094110-101094111 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs567520182 | chr5:101094212-101094213 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs534600394 | chr5:101094213-101094214 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs545491925 | chr5:101094221-101094222 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs79192085 | chr5:101094232-101094233 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs570898481 | chr5:101094276-101094277 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs563730138 | chr5:101094288-101094289 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs538353528 | chr5:101094351-101094352 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs556589278 | chr5:101094394-101094395 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs569934650 | chr5:101094397-101094398 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs375241308 | chr5:101094433-101094434 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs555664556 | chr5:101094462-101094463 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs528219351 | chr5:101094480-101094481 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs2127210 | chr5:101094483-101094484 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs541358525 | chr5:101094484-101094485 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs553374139 | chr5:101094518-101094519 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs375702915 | chr5:101094547-101094548 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs2127211 | chr5:101094551-101094552 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
30 | rs2127212 | chr5:101094605-101094606 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
31 | rs151292967 | chr5:101094640-101094641 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs2127213 | chr5:101094646-101094647 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs189573383 | chr5:101094657-101094658 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs371824325 | chr5:101094720-101094721 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs546536308 | chr5:101094779-101094780 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs570910697 | chr5:101094789-101094790 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs531950982 | chr5:101094800-101094801 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs550276440 | chr5:101094846-101094847 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs1600274 | chr5:101094900-101094901 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs535943719 | chr5:101094901-101094902 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs140616352 | chr5:101094913-101094914 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs113234623 | chr5:101094926-101094927 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs535337269 | chr5:101094975-101094976 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs180703985 | chr5:101095024-101095025 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs183933021 | chr5:101095032-101095033 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs545388416 | chr5:101095052-101095053 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs189448303 | chr5:101095056-101095057 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs150050893 | chr5:101095061-101095062 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs73174566 | chr5:101095062-101095063 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs368032236 | chr5:101095072-101095073 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:101093800-101094000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
2 | chr5:101093800-101094200 | Enhancers | Pancreas | Pancrea |
3 | chr5:101094200-101095200 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr5:101095200-101096200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr5:101095200-101096200 | Enhancers | Adipose Nuclei | Adipose |